TOP TIERMARKET NEWSWIRE
News & sentiment

KALARIS THERAPEUTICS (KLRS) — News & AI sentiment

KALARIS THERAPEUTICS (KLRS) news roundup. 13 stories aggregated over the last 30 days. Average 30-day sentiment is 57.5/100. Recent insider activity (SEC Form 4, 90-day window): 1 purchases totalling $1.2M and 0 sales totalling $0 — net buying of $1.2M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
13
avg sentiment 57.5/100
Insider net (90d)
$1.2M
1 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on KLRS

Kalaris Therapeutics stock falls despite naming new CFO
Investing.com Markets42 · neutralgeneral
Jul 20
Kalaris appoints Liisa Bayko as CFO
Seeking Alpha55 · neutralgeneral
Jul 20
Jul 20
Jul 20
Jul 20
Jul 17
Jul 17
Jul 17
Jul 17
Jul 17
Jul 6
Jul 6
Jul 6
Jun 23
Jun 12
May 25
Open KLRS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →